This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
post featured image
This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy.  The Guide will...
post featured image
Download a copy of our January monthly briefing, which covers key updates and insights in the following areas:  Pharmacies; Clinical...
post featured image
On 31 January 2023, the new Clinical Trials Information System (CTIS) established by Regulation (EU) 536/2014 on clinical trials (CTR)...
post featured image
Early this year, the Portuguese Minister of Health stated the public expense with medicines in 2022 showed an increase of more than EUR...
post featured image
The Swedish government has on 24 January 2023 proposed a bill with actions aimed at improving the availability of medicines. The bill...
post featured image
We would like to invite you to read our report summarising the second edition of the DLA Piper survey "Pharmaceutical and medical sector...
post featured image
During the World Economic Forum 2023 in Davos, specialists discussing the topic of health unanimously indicated that “the past three...
post featured image
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023 into law, which contains the Food and Drug Omnibus...
post featured image
Download a copy of our December monthly briefing, which covers key updates and insights in the following areas:  Clinical trials;...
post featured image
The New Zealand government has introduced the Therapeutic Products Bill which is intended to replace the existing medicines, medical...
post featured image
The FDA has denied two citizen petitions filed on behalf of the Informed Consent Action Network (ICAN) requesting the agency revoke its...
post featured image
The American Enterprise Institute (AEI), a public policy think tank, published a piece this week by Kirsten Axelsen on the potential cost...
post featured image
APIFARMA – Portuguese Pharmaceutical Industry Association (Apifarma) recently approved a revision to the Code of Ethics for Promotion...
post featured image
The FDA has denied two citizen petitions filed on behalf of the Informed Consent Action Network (ICAN) requesting the agency revoke its...
post featured image
We first wrote about the planned amendments to the Pharmaceutical Law and certain other acts (the so-called Verticalisation Act) in...
post featured image
The FDA recently published “Sameness Evaluations in an ANDA – Active Ingredients,” a new draft guidance detailing recommendations for...
post featured image
As someone who believes strongly in empowering women in the workplace and building a diverse and inclusive culture, I really enjoyed...